Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites-Reference-Cited by-同舟云学术

Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites

Published:2016-05 Issue: Volume:107 Page:67-80
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Karkhanis Aneesh,Lam Hui Yuan,Venkatesan Gopalakrishnan,Koh Siew Kwan,Chai Christina Li Lin,Zhou Lei,Hong Yanjun,Kojodjojo Pipin,Chan Eric Chun Yong^ORCID

Funder

Singapore Ministry of Education Tier 1 Academic Research Funding

National University of Singapore

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference41 articles.

1. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study;Chugh;Circulation,2014

2. The cost of illness of atrial fibrillation: a systematic review of the recent literature;Wolowacz;Europace,2011

3. Epidemiological profile of atrial fibrillation: a contemporary perspective;Tsang;Prog. Cardiovasc. Dis.,2005

4. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle;Singh;Br. J. Pharmacol.,1970

5. Dronedarone: a new antiarrhythmic agent;Oyetayo;Pharmacotherapy,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control;Pharmacology & Therapeutics;2024-06

2. Sorafenib reduces the production of epoxyeicosatrienoic acids and leads to cardiac injury by inhibiting CYP2J in rats;Biochemical Pharmacology;2024-05

3. Investigating the association between CYP2J2 inhibitors and QT prolongation: a literature review;Drug Metabolism Reviews;2024-03-20

4. Unraveling a Combined Inactivation Mechanism of Cytochrome P450s by Genipin, the Major Reactive Aglycone Derived from Gardeniae Fructus;Chemical Research in Toxicology;2023-08-25

5. Investigating the relevance of CYP2J2 inhibition for drugs known to cause intermediate to high risk torsades de pointes;European Journal of Pharmaceutical Sciences;2023-08